Home LiteratureArticle Details
PMID: 19074875 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest.

Cancer research ·Vol. 68 ·No. 24 ·2008-12-15 ·Pages 10094-104

Braun CJ, Zhang X, Savelyeva I, Wolff S, Moll UM, Schepeler T, Ørntoft TF, Andersen CL, Dobbelstein M

Abstract

microRNAs provide a novel layer of regulation for gene expression by interfering with the stability and/or translation of specific target mRNAs. Overall levels of microRNAs are frequently down-regulated in cancer cells, and reducing general microRNA processing increases cancerogenesis in transgenic models, suggesting that at least some microRNAs might act as effectors in tumor suppression. Accordingly, the tumor suppressor p53 up-regulates miR-34a, a microRNA that contributes to apoptosis and acute senescence. Here, we used array hybridization to find that p53 induces two additional, mutually related clusters of microRNAs, leading to the up-regulation of miR-192, miR-194, and miR-215. The same microRNAs were detected at high levels in normal colon tissue but were severely reduced in many colon cancer samples. On the other hand, miR-192 and its cousin miR-215 can each contribute to enhanced CDKN1A/p21 levels, colony suppression, cell cycle arrest, and cell detachment from a solid support. These effects were partially dependent on the presence of wild-type p53. Antagonizing endogenous miR-192 attenuated 5-fluorouracil-induced accumulation of p21. Hence, miR-192 and miR-215 can act as effectors as well as regulators of p53; they seem to suppress cancerogenesis through p21 accumulation and cell cycle arrest.

MeSH Terms
Bone Neoplasms/genetics,metabolism,pathology Cell Adhesion/genetics Cell Cycle/genetics Cell Line, Tumor Colonic Neoplasms/genetics,metabolism,pathology Cyclin-Dependent Kinase Inhibitor p21/biosynthesis,genetics Genes, p53 HCT116 Cells HT29 Cells Humans Imidazoles/pharmacology MicroRNAs/antagonists & inhibitors,biosynthesis,genetics Neoplasms/genetics,metabolism,pathology Oligonucleotide Array Sequence Analysis Osteosarcoma/genetics,metabolism,pathology Piperazines/pharmacology Proto-Oncogene Proteins c-mdm2/metabolism Transfection Tumor Suppressor Protein p53/genetics,metabolism Up-Regulation
Chemicals
CDKN1A protein, human Cyclin-Dependent Kinase Inhibitor p21 Imidazoles MicroRNAs Piperazines TP53 protein, human Tumor Suppressor Protein p53 nutlin 3 MDM2 protein, human Proto-Oncogene Proteins c-mdm2
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Braun Christian J
Department of Molecular Oncology, Göttingen Center of Molecular Biosciences, University of Göttingen, Göttingen, Germany.
Zhang Xin
Savelyeva Irina
Wolff Sonja
Moll Ute M
Schepeler Troels
Ørntoft Torben F
Andersen Claus L
Dobbelstein Matthias
References (43)
43 references, click to expand
  1. Regulatory interaction of HNF1-alpha to microRNA-194 gene during intestinal epithelial cell differentiation.
    Nucleic Acids Symp Ser (Oxf). 2007;(51):415-6 PMID: 18029763
  2. Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study.
    J Clin Oncol. 2007 Mar 1;25(7):767-72 PMID: 17228023
  3. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.
    Mol Cell. 2007 Jun 8;26(5):745-52 PMID: 17540599
  4. Requirement for p53 and p21 to sustain G2 arrest after DNA damage.
    Science. 1998 Nov 20;282(5393):1497-501 PMID: 9822382
  5. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
    Nat Rev Genet. 2008 Feb;9(2):102-14 PMID: 18197166
  6. Induction of p21CIP/WAF-1 and G2 arrest by ionizing irradiation impedes caspase-3-mediated apoptosis in human carcinoma cells.
    Oncogene. 2006 Feb 16;25(7):972-80 PMID: 16331277
  7. Disruption of p53 in human cancer cells alters the responses to therapeutic agents.
    J Clin Invest. 1999 Aug;104(3):263-9 PMID: 10430607
  8. Definition of a consensus binding site for p53.
    Nat Genet. 1992 Apr;1(1):45-9 PMID: 1301998
  9. Amplification of a gene encoding a p53-associated protein in human sarcomas.
    Nature. 1992 Jul 2;358(6381):80-3 PMID: 1614537
  10. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215.
    Cancer Res. 2008 Dec 15;68(24):10105-12 PMID: 19074876
  11. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.
    Cell. 2006 Mar 24;124(6):1169-81 PMID: 16564011
  12. The guardian's little helper: microRNAs in the p53 tumor suppressor network.
    Cancer Res. 2007 Dec 1;67(23):11099-101 PMID: 18056431
  13. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.
    Cell. 2005 Jul 1;121(7):1071-83 PMID: 15989956
  14. Molecular mechanisms of "detachment-induced apoptosis--Anoikis".
    Apoptosis. 2002 Jun;7(3):247-60 PMID: 11997669
  15. p53 in health and disease.
    Nat Rev Mol Cell Biol. 2007 Apr;8(4):275-83 PMID: 17380161
  16. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
    Cancer Res. 2007 Sep 15;67(18):8433-8 PMID: 17823410
  17. Failure of epithelial tube maintenance causes hydrocephalus and renal cysts in Dlg5-/- mice.
    Dev Cell. 2007 Sep;13(3):338-50 PMID: 17765678
  18. p53 enters the microRNA world.
    Cancer Cell. 2007 Nov;12(5):414-8 PMID: 17996645
  19. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.
    Science. 2004 Feb 6;303(5659):844-8 PMID: 14704432
  20. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors.
    Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3432-7 PMID: 17360662
  21. Impaired microRNA processing enhances cellular transformation and tumorigenesis.
    Nat Genet. 2007 May;39(5):673-7 PMID: 17401365
  22. Tiny actors, great roles: microRNAs in p53's service.
    Cell Cycle. 2007 Nov 1;6(21):2656-61 PMID: 17957137
  23. Silencing of microRNAs in vivo with 'antagomirs'.
    Nature. 2005 Dec 1;438(7068):685-9 PMID: 16258535
  24. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.
    Cell Cycle. 2007 Jul 1;6(13):1586-93 PMID: 17554199
  25. Mdmx and Mdm2: brothers in arms?
    Cell Cycle. 2004 Jul;3(7):900-4 PMID: 15254433
  26. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells.
    Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15472-7 PMID: 17875987
  27. microRNAs join the p53 network--another piece in the tumour-suppression puzzle.
    Nat Rev Cancer. 2007 Nov;7(11):819-22 PMID: 17914404
  28. A simple array platform for microRNA analysis and its application in mouse tissues.
    RNA. 2007 Oct;13(10):1803-22 PMID: 17675362
  29. MicroRNA-cancer connection: the beginning of a new tale.
    Cancer Res. 2006 Aug 1;66(15):7390-4 PMID: 16885332
  30. Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression.
    Cell. 2007 Dec 14;131(6):1097-108 PMID: 18083100
  31. Real-time quantification of microRNAs by stem-loop RT-PCR.
    Nucleic Acids Res. 2005 Nov 27;33(20):e179 PMID: 16314309
  32. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.
    Mol Cell. 2007 Jun 8;26(5):731-43 PMID: 17540598
  33. Locus-specific mutation databases: pitfalls and good practice based on the p53 experience.
    Nat Rev Cancer. 2006 Jan;6(1):83-90 PMID: 16397528
  34. The p53MH algorithm and its application in detecting p53-responsive genes.
    Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8467-72 PMID: 12077306
  35. p53-mediated activation of miRNA34 candidate tumor-suppressor genes.
    Curr Biol. 2007 Aug 7;17(15):1298-307 PMID: 17656095
  36. MicroRNA expression profiles classify human cancers.
    Nature. 2005 Jun 9;435(7043):834-8 PMID: 15944708
  37. A mammalian microRNA expression atlas based on small RNA library sequencing.
    Cell. 2007 Jun 29;129(7):1401-14 PMID: 17604727
  38. Getting to the root of miRNA-mediated gene silencing.
    Cell. 2008 Jan 11;132(1):9-14 PMID: 18191211
  39. Widespread microRNA repression by Myc contributes to tumorigenesis.
    Nat Genet. 2008 Jan;40(1):43-50 PMID: 18066065
  40. A microRNA component of the p53 tumour suppressor network.
    Nature. 2007 Jun 28;447(7148):1130-4 PMID: 17554337
  41. Transcription-independent pro-apoptotic functions of p53.
    Curr Opin Cell Biol. 2005 Dec;17(6):631-6 PMID: 16226451
  42. MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues.
    Genome Res. 2004 Dec;14(12):2486-94 PMID: 15574827
  43. Loss of p21 disrupts p14 ARF-induced G1 cell cycle arrest but augments p14 ARF-induced apoptosis in human carcinoma cells.
    Oncogene. 2005 Jun 9;24(25):4114-28 PMID: 15750619
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
1538-7445
Published
2008-12-15
Pages
10094-104
Language
English
Region
United States
NLM ID
2984705R
PMCID
PMC2836584
Subset
IM
Grants
NCI NIH HHS · R01 CA060664 · United States
NCI NIH HHS · R01 CA060664-13 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com